Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.
Eur J Immunol
; 49(1): 195-198, 2019 01.
Article
en En
| MEDLINE
| ID: mdl-30267564
ABSTRACT
Intravenous immunoglobuin (IVIG) exerts protective effects in experimental allergic bronchopulmonary aspergillosis (ABPA) via a sialylation-dependent mechanism. The protection was associated with reduced recruitment of eosinophils, diminished goblet cell hyperplasia, suppressed Th2 and Th17 responses and reciprocally enhanced regulatory T cells and IL-10, and decreased IgE levels in the circulation.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Aspergilosis Broncopulmonar Alérgica
/
Inmunoglobulinas Intravenosas
/
Linfocitos T Reguladores
/
Células Th2
/
Células Caliciformes
/
Eosinófilos
/
Células Th17
Límite:
Animals
/
Humans
Idioma:
En
Año:
2019
Tipo del documento:
Article